Literature DB >> 30529801

Hydrogen as a complementary therapy against ischemic stroke: A review of the evidence.

He Li1, Yin Luo2, Pengfei Yang2, Jianmin Liu3.   

Abstract

Ischemic stroke is one of the most common sources of mortality in the world. Researchers have been trying to find a complementary therapy to treat ischemic stroke in order to improve its prognosis and expand the therapeutic window for reperfusion treatment. For this reason, many experimental and clinical trials studying the effects of hydrogen against ischemic stroke have been published. Hydrogen gas has been found to eliminate hydroxyl free radical and peroxynitrite anions as well as producing therapeutic effect in patients with ischemic stroke. Many studies have been published illustrating its anti-oxidative, anti-inflammatory and anti-apoptotic effects. The purpose of this article is to review the literature concerning treatment of cerebral I/R injury or ischemic stroke with hydrogen therapy. Specifically, we will examine the appropriate laboratory methods, mechanisms of hydrogen therapy, and outcomes of relevant clinical trials. We conclude this review with a discussion on future investigations of hydrogen therapy to treat ischemic stroke.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Clinical trial; Hydrogen therapy; Ischemic stroke; Mechanism; Model

Mesh:

Substances:

Year:  2018        PMID: 30529801     DOI: 10.1016/j.jns.2018.11.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Molecular Hydrogen Mediates Neurorestorative Effects After Stroke in Diabetic Rats: the TLR4/NF-κB Inflammatory Pathway.

Authors:  Wan-Chao Yang; Ting-Ting Li; Qiang Wan; Xin Zhang; Li-Ying Sun; Yu-Rong Zhang; Pei-Chen Lai; Wen-Zhi Li
Journal:  J Neuroimmune Pharmacol       Date:  2022-07-27       Impact factor: 7.285

2.  Hydrogen-Rich Saline Regulates Microglial Phagocytosis and Restores Behavioral Deficits Following Hypoxia-Ischemia Injury in Neonatal Mice via the Akt Pathway.

Authors:  Hongfei Ke; Dexiang Liu; Tingting Li; Xili Chu; Danqing Xin; Min Han; Shuanglian Wang; Zhen Wang
Journal:  Drug Des Devel Ther       Date:  2020-09-21       Impact factor: 4.162

3.  Systematic Investigation of the Effect of Powerful Tianma Eucommia Capsule on Ischemic Stroke Using Network Pharmacology.

Authors:  Pengcheng Feng; Guixia Li; Yan Huang; Jinhong Pei
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-04       Impact factor: 2.629

Review 4.  Blood-brain barrier dysfunction in ischemic stroke and diabetes: the underlying link, mechanisms and future possible therapeutic targets.

Authors:  Piyawadee Wicha; Srijit Das; Pasuk Mahakkanukrauh
Journal:  Anat Cell Biol       Date:  2021-06-30

Review 5.  Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?

Authors:  Ryszard Pluta; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 6.  Role of Connexins 30, 36, and 43 in Brain Tumors, Neurodegenerative Diseases, and Neuroprotection.

Authors:  Oscar F Sánchez; Andrea V Rodríguez; José M Velasco-España; Laura C Murillo; Jhon-Jairo Sutachan; Sonia-Luz Albarracin
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

7.  Hydrogen-rich saline mitigates pressure overload-induced cardiac hypertrophy and atrial fibrillation in rats via the JAK-STAT signalling pathway.

Authors:  Chufeng Wang; Zezheng Pan
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

8.  Formulation and Characterization of an Effervescent Hydrogen-Generating Tablet.

Authors:  Moritz Rosch; Kurt Lucas; Jozef Al-Gousous; Ulrich Pöschl; Peter Langguth
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.